1997
DOI: 10.1001/archderm.133.6.767
|View full text |Cite
|
Sign up to set email alerts
|

Endogenous retroviral sequences in the pathogenesis of systemic autoimmune disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

1997
1997
2004
2004

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 0 publications
0
8
0
Order By: Relevance
“…It is estimated that endogenous retroviral sequences (ERVs) make up at least 1% of total genomic DNA (8). ERVs may potentially affect the development and outcome of a retroviral infection (9 -11).…”
Section: Urine Aids (Maids)mentioning
confidence: 99%
“…It is estimated that endogenous retroviral sequences (ERVs) make up at least 1% of total genomic DNA (8). ERVs may potentially affect the development and outcome of a retroviral infection (9 -11).…”
Section: Urine Aids (Maids)mentioning
confidence: 99%
“…Recent data indicate that the classification of type 1 and 2 Th cells according to their cytokine profile may also be the case for CD8 þ T cell subsets [3][4][5][6]. Humoral immune defects are often found in clinical disorders with an autoimmunerelated background, retroviral infections or B cell malignancies such as myeloma and chronic B cell leukaemia (B-CLL) [7][8][9][10]. Reduction of polyclonal immunoglobulins found in these disorders may involve common pathogenic pathways, since autoimmune-related features are frequently observed in B-CLL patients, and patients with systemic autoimmune disease are more prone to developing malignant B cell disorders [8,9,11].…”
Section: Introductionmentioning
confidence: 99%
“…Humoral immune defects are often found in clinical disorders with an autoimmunerelated background, retroviral infections or B cell malignancies such as myeloma and chronic B cell leukaemia (B-CLL) [7][8][9][10]. Reduction of polyclonal immunoglobulins found in these disorders may involve common pathogenic pathways, since autoimmune-related features are frequently observed in B-CLL patients, and patients with systemic autoimmune disease are more prone to developing malignant B cell disorders [8,9,11]. Common immunological abnormalities are elevation of IL-6 and IL-10 levels as well as down-regulation of IFN-g [9,[12][13][14][15], indicating a lack of type 1 cytokines.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations